APA

Inada S., Tomidokoro T., Fukunari H., Sato T., Hatano T., Nishimura A., Kawauchi Y., Nikkuni K., Shimizu T., Sato T., Yanagi M., Takahashi S., Yoshida H., Sugita M. & Hayashi T. (20081222). Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. : Cancer chemotherapy and pharmacology.

Chicago

Inada Seisuke, Tomidokoro Takashi, Fukunari Hiroyuki, Sato Tomomi, Hatano Toru, Nishimura Atsushi, Kawauchi Yasuyuki, Nikkuni Keiya, Shimizu Takeaki, Sato Toshiteru, Yanagi Masahiko, Takahashi Satoru, Yoshida Hideki, Sugita Minoru and Hayashi Tetsuji. 20081222. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. : Cancer chemotherapy and pharmacology.

Harvard

Inada S., Tomidokoro T., Fukunari H., Sato T., Hatano T., Nishimura A., Kawauchi Y., Nikkuni K., Shimizu T., Sato T., Yanagi M., Takahashi S., Yoshida H., Sugita M. and Hayashi T. (20081222). Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. : Cancer chemotherapy and pharmacology.

MLA

Inada Seisuke, Tomidokoro Takashi, Fukunari Hiroyuki, Sato Tomomi, Hatano Toru, Nishimura Atsushi, Kawauchi Yasuyuki, Nikkuni Keiya, Shimizu Takeaki, Sato Toshiteru, Yanagi Masahiko, Takahashi Satoru, Yoshida Hideki, Sugita Minoru and Hayashi Tetsuji. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. : Cancer chemotherapy and pharmacology. 20081222.